Impax Laboratories downgraded

|About: Impax Laboratories, Inc. (IPXL)|By:, SA News Editor

Impax Laboratories (IPXL -0.1%) catches a downgrade to Underperform from Neutral at Buckingham Research.

Price target is $15 (unchanged from previous), nearly 31% below Friday's close.